Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 40.91%
March 31, 2026 42.25%
December 31, 2025 37.98%
September 30, 2025 42.04%
June 30, 2025 42.30%
March 31, 2025 47.14%
December 31, 2024 43.66%
September 30, 2024 41.29%
June 30, 2024 44.62%
March 31, 2024 44.39%
December 31, 2023 39.56%
September 30, 2023 39.02%
June 30, 2023 38.55%
March 31, 2023 38.55%
December 31, 2022 33.65%
September 30, 2022 39.95%
June 30, 2022 30.69%
March 31, 2022 40.23%
December 31, 2021 20.96%
September 30, 2021 24.88%
June 30, 2021 37.43%
March 31, 2021 35.87%
December 31, 2020 32.23%
September 30, 2020 41.96%
June 30, 2020 33.59%
Date Value
March 31, 2020 34.40%
December 31, 2019 37.69%
September 30, 2019 38.90%
March 31, 2019 41.74%
December 31, 2018 44.09%
September 30, 2018 16.82%
June 30, 2018 31.53%
March 31, 2018 40.23%
December 31, 2017 32.57%
September 30, 2017 28.14%
June 30, 2017 35.98%
March 31, 2017 19.73%
December 31, 2016 20.48%
September 30, 2016 32.40%
June 30, 2016 29.52%
March 31, 2016 32.28%
December 31, 2015 31.42%
September 30, 2015 23.08%
June 30, 2015 18.91%
March 31, 2015 4.39%
December 31, 2014 31.20%
September 30, 2014 25.51%
June 30, 2014 -0.42%
March 31, 2014 24.74%
December 31, 2013 36.29%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
BioLineRx Ltd. 53.41%
XTL Biopharmaceuticals Ltd. --
Can-Fite BioPharma Ltd. --
Eocene Ltd. --
Revium Recovery, Inc. --

Gross Profit Margin (Quarterly) Related Metrics